Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1050055

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 October 2018 to Question 174612 on Air pollution, what evidence he is using to assess the safe limit for public health of inhalation of PM0.1 and PM1 particles.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	213199
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The reviews by the Health Effects Institute and World Health Organization of the effects of different components of air pollution, including ultrafine particles (PM0.1), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reviews are both available to view at the following links:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom. This was based on studies reporting associations of mortality risk with fine particulate matter (PM2.5), which includes PM1 and PM0.1, and nitrogen dioxide (NO<sub>2</sub>). Findings of these assessments are available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality" target="_blank">https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality</a></p><p> </p><p>No separate assessment of the impact of PM1 and PM0.1 components of particulate air pollution has been produced.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:25:44 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1050056

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 15 October 2018 to Question 174612, Air Pollution, as the COMEAP study to which he refers was carried out in 2012, if he will (a) ask that body to conduct a further study on the effects of particulate air pollution on mortality in the UK and (b) will ensure that such a new study includes PM0.1 and PM1.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	213200
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Recent assessments have been undertaken of the health effects of long-term exposure to the air pollution mixture in the United Kingdom, based on studies reporting associations of mortality risk with fine particulate matter (PM2.5), which includes PM1 and PM0.1, and nitrogen dioxide (NO<sub>2</sub>). No separate assessments of the impact of the PM1 and PM0.1 components (particulate matter with an aerodynamic diameter smaller than 1 or 0.1 microns respectively) of particulate air pollution have been produced. The recent Committee on the Medical Effects of Air Pollutants assessment is available to view at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality" target="_blank">https://www.gov.uk/government/publications/nitrogen-dioxide-effects-on-mortality</a></p><p> </p><p>The reviews by the Health Effects Institute and World Health Organization of the effects of different components of air pollution, including ultrafine particles (PM0.1), concluded that there is currently limited evidence on the effects on health of ultrafine particles. These reviews are available at the following links:</p><p> </p><p><a href="https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles" target="_blank">https://www.healtheffects.org/publication/understanding-health-effects-ambient-ultrafine-particles</a></p><p> </p><p><a href="http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1" target="_blank">http://www.euro.who.int/__data/assets/pdf_file/0004/193108/REVIHAAP-Final-technical-report-final-version.pdf?ua=1</a></p><p> </p><p>Currently, Public Health England has no plans to engage in work on the effects of PM1 and PM0.1 particles on human health.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:19:38 answering member 4067 label Biography information for Steve Brine
	tabling member	252 label Biography information for Dr David Drew

1049987

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Alcoholic Drinks: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce underage drinking.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	213353
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Local authorities are responsible for assessing local need and commissioning prevention initiatives and alcohol and drug services for young people, using the public health grant.</p><p> </p><p>Public Health England (PHE) and the Home Office fund Mentor UK’s Alcohol and Drug Education and Prevention Information Service which provides evidence-based practical advice and tools, including briefing sheets for teachers, available to view at the following link:</p><p> </p><p><a href="http://mentor-adepis.org/" target="_blank">http://mentor-adepis.org/</a></p><p> </p><p>PHE’s Rise Above social marketing programme aims to equip 11 to 16 year olds with the skills required to reject or manage risky behaviours, including drinking alcohol. It reaches young people via social media and provides accredited lesson plans for use in secondary schools. The Rise Above website is available at the following link:</p><p> </p><p><a href="https://riseabove.org.uk/" target="_blank">https://riseabove.org.uk/</a></p><p> </p><p>The protection of children is one of four licensing objectives that local licensing authorities are required to uphold. A mandatory licence condition requires all licensed premises to have a policy on age verification and to require anyone who appears under 18 to verify their age.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:18:06 answering member 4067 label Biography information for Steve Brine
	tabling member	4131 label Biography information for Jim Shannon

1050101

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asparaginase
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207238 on Asparaginase, what steps Porton Biopharma will take to increase capacity of erwinase and better supply the (a) UK and (b) world market for the remainder of 2019.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	213322
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Porton Biopharma Ltd (PBL) are implementing a series of initiatives to increase capacity and supply in both the short and long term. These include the following:</p><p>- Extending operational activities to 24 hours a day, seven days a week to maximise fermentation of the product;</p><p>- Implementing an ongoing capital programme including construction of a new pharmaceutical fermentation facility. The facility was completed in April 2018 and is currently undergoing testing; it has an increased capacity fermentation suite which will enable PBL to manufacture at larger scale and is due to start producing product Q3 2019 for regulatory approval to market;</p><p>- A new filling and freeze-drying building was completed in February 2016. The installation of a new filling line which covers the entire process, including vial washing, filling, stoppering and freeze drying. The new line has been designed with systems which monitor all critical parameters throughout the process to accelerate batch release and will accommodate increased capacity. The beneficial use of this and the fermentation facility will coincide to maximise increased product output; and</p><p>- Sourcing replacement suppliers, including for new stoppers and new vials for the product, ensuring that maximum batch sizes can be achieved with minimal product rejects. This programme is complete.</p><p> </p><p>PBL has made significant investments into increasing product capacity and will continue to release future batches as soon as they become available to Jazz Pharmaceuticals (who are responsible for the packaging/distribution and allocation of worldwide product supply).</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:09:48 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1050075

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bacteriophages
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using bacteriophages as an alternative to antibiotics.
	tabling member constituency	Portsmouth South
	tabling member printed	Stephen Morgan
	uin	213453
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The Department and the Wellcome Trust sponsored a strategic pipeline briefing into alternatives to antibiotics in 2015. The briefing reviewed the feasibility and potential clinical impact of alternatives to antibiotics, including bacteriophages, and considered approaches that were most likely to deliver new treatments in the next 10 years. The briefing concluded that bacteriophages were possible therapeutics, but too few were being progressed.</p><p> </p><p>The Government continues to invest in research into new and alternative treatments. While there has been increased investment and unprecedented levels of research collaboration on antimicrobial resistance, there are still relatively few projects looking at the use of bacteriophages.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 14:59:34 answering member 4067 label Biography information for Steve Brine
	tabling member	4653 label Biography information for Stephen Morgan

1052360

	registered interest
	date	31/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to page 7 of the National Audit Report's investigation into the management of health screening, published on 30 January 2019, how his Department plans to ensure that the standard for repeat breast screenings which guarantees an appointment within 36 months of a previous appointment is met with 100 per cent success.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	215172
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The NHS Breast Screening Programme minimum standard is that 90% of women should be re-invited within 36 months of their previous screen.</p><p> </p><p>The Department delegates NHS England to commission breast screening providers to work to the agreed national service specifications and provides supporting guidance produced by Public Health England (PHE) to ensure standards are met.</p><p> </p><p>Improvements to the current repeat breast screening interval (round length) to meet national standards require providers to balance ever changing parameters, such as the eligible population, availability of breast screening workforce, estates and the logistics of the mobile units, used for mammography.</p><p> </p><p>PHE is addressing the current workforce issue through supporting key stakeholders including Health Education England, the Royal College of Radiologists, and the Society and College of Radiographers to assist in workforce recruitment and retention of Radiographers and Radiologists. NHS England, at local level, is using the framework of the National Health Service contract to work with providers and PHE to also improve this standard.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:16:24 answering member 4067 label Biography information for Steve Brine
	tabling member	4036 label Biography information for Luciana Berger

1050071

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dementia
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to page 15 of the NHS Long Term Plan, published in January 2019, whether the revised GP Quality Outcomes Framework (QOF) proposed in that plan will effect QOF indicators for dementia including (a) new diagnoses, (b) care plans or memory assessment reviews and (c) named carers on records.
	tabling member constituency	Worsley and Eccles South
	tabling member printed	Barbara Keeley
	uin	213303
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>Major reform to the GP contract was announced at the NHS England Board meeting on 31 January 2019, which sets out significant investment in general practice, including a focus upon improving care to some of the most vulnerable patients through a multidisciplinary approach. Further information is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/gp/gpfv/investment/gp-contract/" target="_blank">https://www.england.nhs.uk/gp/gpfv/investment/gp-contract/</a></p><p> </p><p>It also included changes to the Quality Outcomes Framework (QOF), reflecting the recommendations of the QOF Review published by NHS England in July 2018 is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2018/07/quality-outcome-framework-report-of-the-review.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2018/07/quality-outcome-framework-report-of-the-review.pdf</a></p><p> </p><p>Key changes to the QOF include:</p><p>- The retirement of 28 indicators which are either no longer in line with National Institute for Health and Care Excellence guidance, suffer from known measurement problems (usually because of small numbers at a practice level) or represent core general practice activities (175 points);</p><p>- The introduction of 15 new indicators in relation to blood pressure management, diabetes, cervical screening, chronic obstructive pulmonary disease and mental health (101 points). These should lead to improvements in patient care and ultimately outcomes;</p><p>- The replacement of exception reporting with a personalised care adjustment which recognises the necessity for practices to be able to tailor care to individual patients; and</p><p>- The introduction of a quality improvement domain worth 74 points in 2019/20 and, in the first year, focused upon prescribing safety and end of life care.</p><p> </p><p>A number of further reviews of the QOF domains are planned, including that for mental health. In relation to dementia specifically, the current indicator DEM005 (pre-diagnosis blood tests) will be retired due to the small numbers at practice level. This decision is in line with the recommendations of the QOF review. There are no changes to the other two dementia care indicators which focus upon identification and care planning.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 05/02/2019 15:12:42 answering member 4067 label Biography information for Steve Brine
	tabling member	1588 label Biography information for Barbara Keeley

1050140

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Expenditure
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June 2018 to Question 147920 on NHS: Dental Services, what the total expenditure was on NHS dental services (a) gross and (b) net of patient charge revenue in 2017-18.
	tabling member constituency	Bootle
	tabling member printed	Peter Dowd
	uin	213397
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The following table shows total gross and net expenditure on National Health Service primary care dental services, total expenditure on such services net of patient charge revenue per head of population and the proportion of patient charge revenue to total expenditure for such services for 2017/18.</p><p> </p><table><tbody><tr><td><p>NHS Dentistry</p></td><td><p>2017/18</p></td></tr><tr><td><p>Gross expenditure (millions)<sup>2</sup></p></td><td><p>2,812</p></td></tr><tr><td><p>Patient Charge Revenue (millions)<sup>2</sup></p></td><td><p>807</p></td></tr><tr><td><p>Net Expenditure (millions)</p></td><td><p>2,004</p></td></tr><tr><td><p>Mid-year population estimate (millions)<sup>1</sup></p></td><td><p>55.6</p></td></tr><tr><td><p>Net expenditure per capita</p></td><td><p>£36.04</p></td></tr><tr><td><p>Patient charge revenue as a percentage of expenditure on total NHS dental services</p></td><td><p>28.7%</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Source for mid-year population estimates: Office for National Statistics</p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop</a></p><p> </p><p><sup>2</sup>Source: the Department of Health and Social Care Annual Report and Accounts, Fees and Charges disclosure for each financial year</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213398 213399 question first answered 05/02/2019 15:21:25 answering member 4067 label Biography information for Steve Brine
	tabling member	4397 label Biography information for Peter Dowd

1050142

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the answer of 5 June to Question 147921 on NHS: Dental Services, what the patient charge revenue was in 2017-18 (a) in total and (b) as a proportion of the total expenditure on NHS dental services.
	tabling member constituency	Bootle
	tabling member printed	Peter Dowd
	uin	213399
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The following table shows total gross and net expenditure on National Health Service primary care dental services, total expenditure on such services net of patient charge revenue per head of population and the proportion of patient charge revenue to total expenditure for such services for 2017/18.</p><p> </p><table><tbody><tr><td><p>NHS Dentistry</p></td><td><p>2017/18</p></td></tr><tr><td><p>Gross expenditure (millions)<sup>2</sup></p></td><td><p>2,812</p></td></tr><tr><td><p>Patient Charge Revenue (millions)<sup>2</sup></p></td><td><p>807</p></td></tr><tr><td><p>Net Expenditure (millions)</p></td><td><p>2,004</p></td></tr><tr><td><p>Mid-year population estimate (millions)<sup>1</sup></p></td><td><p>55.6</p></td></tr><tr><td><p>Net expenditure per capita</p></td><td><p>£36.04</p></td></tr><tr><td><p>Patient charge revenue as a percentage of expenditure on total NHS dental services</p></td><td><p>28.7%</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Source for mid-year population estimates: Office for National Statistics</p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop</a></p><p> </p><p><sup>2</sup>Source: the Department of Health and Social Care Annual Report and Accounts, Fees and Charges disclosure for each financial year</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213397 213398 question first answered 05/02/2019 15:21:25 answering member 4067 label Biography information for Steve Brine
	tabling member	4397 label Biography information for Peter Dowd

1050141

	registered interest
	date	28/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Per Capita Costs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 June to Question 147920 on NHS: Dental Services, what the expenditure was on NHS dental services net of patient charge revenue per head of population in 2017-18.
	tabling member constituency	Bootle
	tabling member printed	Peter Dowd
	uin	213398
	answer	answer is ministerial correction date of answer 05/02/2019 answer text <p>The following table shows total gross and net expenditure on National Health Service primary care dental services, total expenditure on such services net of patient charge revenue per head of population and the proportion of patient charge revenue to total expenditure for such services for 2017/18.</p><p> </p><table><tbody><tr><td><p>NHS Dentistry</p></td><td><p>2017/18</p></td></tr><tr><td><p>Gross expenditure (millions)<sup>2</sup></p></td><td><p>2,812</p></td></tr><tr><td><p>Patient Charge Revenue (millions)<sup>2</sup></p></td><td><p>807</p></td></tr><tr><td><p>Net Expenditure (millions)</p></td><td><p>2,004</p></td></tr><tr><td><p>Mid-year population estimate (millions)<sup>1</sup></p></td><td><p>55.6</p></td></tr><tr><td><p>Net expenditure per capita</p></td><td><p>£36.04</p></td></tr><tr><td><p>Patient charge revenue as a percentage of expenditure on total NHS dental services</p></td><td><p>28.7%</p></td></tr></tbody></table><p> </p><p><sup>1</sup>Source for mid-year population estimates: Office for National Statistics</p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/timeseries/enpop/pop</a></p><p> </p><p><sup>2</sup>Source: the Department of Health and Social Care Annual Report and Accounts, Fees and Charges disclosure for each financial year</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 213397 213399 question first answered 05/02/2019 15:21:25 answering member 4067 label Biography information for Steve Brine
	tabling member	4397 label Biography information for Peter Dowd